PDCD1 and neoplasm: For this we used an RNA-seq dataset from baseline tumor biopsies from patients included in the NeoNivo clinical trial, in which sixteen patients with locally-advanced OCSCC received one dose of the anti-PD-1 drug nivolumab prior to surgery [17].